| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.08B | 149.37B | 135.63B | 129.29B | 109.33B | 109.64B |
| Gross Profit | 23.24B | 24.73B | 23.01B | 18.77B | 15.51B | 15.75B |
| EBITDA | 13.38B | 14.06B | 13.49B | 8.96B | 6.75B | 7.43B |
| Net Income | 8.07B | 9.33B | 8.22B | 5.05B | 3.79B | 4.54B |
Balance Sheet | ||||||
| Total Assets | 117.17B | 142.46B | 132.57B | 123.98B | 116.08B | 93.10B |
| Cash, Cash Equivalents and Short-Term Investments | 13.33B | 9.34B | 22.10B | 11.16B | 9.35B | 9.95B |
| Total Debt | 9.47B | 28.30B | 19.57B | 21.09B | 30.86B | 10.62B |
| Total Liabilities | 60.02B | 76.97B | 74.68B | 71.81B | 68.21B | 47.56B |
| Stockholders Equity | 57.14B | 65.49B | 57.88B | 52.17B | 47.87B | 45.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -18.68B | 14.95B | 13.94B | -18.31B | 1.31B |
| Operating Cash Flow | 0.00 | -17.47B | 15.95B | 15.94B | -16.71B | 2.60B |
| Investing Cash Flow | 0.00 | -506.00M | -807.00M | -1.92B | -1.96B | -1.15B |
| Financing Cash Flow | 0.00 | 5.24B | -4.21B | -12.22B | 18.06B | -1.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥133.17B | 8.72 | ― | 2.81% | 5.14% | 18.79% | |
65 Neutral | ¥213.54B | 8.89 | ― | 3.82% | 7.97% | 37.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥124.37B | 9.43 | ― | 2.89% | 16.39% | 101.50% | |
63 Neutral | ¥80.30B | 9.52 | ― | 3.63% | 20.40% | 50.00% | |
62 Neutral | ¥148.20B | 11.42 | ― | 3.44% | 1.86% | 11.05% | |
59 Neutral | ¥102.62B | 10.71 | ― | 3.13% | 10.13% | 13.31% |